Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Eloralintide for Sale > Eloralintide cas: 2883634-40-8 Not For Human Use, Lab Use Only.
Eloralintide cas: 2883634-40-8 Not For Human Use, Lab Use Only. buy - large image1
Eloralintide cas: 2883634-40-8 Not For Human Use, Lab Use Only. buy - image1

Eloralintide cas: 2883634-40-8 Not For Human Use, Lab Use Only.

81 Inquiries

Unit Price: Get Latest Price
CAS No.:

2883634-40-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Hangzhou

Brand:

N/A

Packaging:

1g/bottle,1kg/bag

Price valid (until):

2025-12-13

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents
Average Lead Time:
7 days
Qualification:
Main Products:

Pharmaceutical Peptide,Cosmetic peptide,Custom peptides,API polypeptide,Amino acids and derivatives,Peptide - Teriparatide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Eloralintide (LY 3841136) is an AMYR agonist, which is promising for research of type 2 diabetes and obesity.

    Eloralintide is a long-acting amylin receptor agonist and structural analog of the natural hormone amylin, which is co-secreted with insulin by pancreatic β-cells. It has been developed as a potent metabolic modulator that mimics the physiological effects of amylin, including appetite regulation and glucose control.

    Items Specifications
    M.Wt 4526.10
    Formula C201H319N49O65S2
    Chemical Name/SMILES Sequence: {γGlu}-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gly-{Orn}-Leu-Ala-Glu-{(α-Me-Phe)}-Leu-Val-Arg-Ser-Ser-Asn-{(N-Me-Asn)}-Phe-Gly-Pro-{Lys(γGlu-γGlu-C20 diacid)}-Leu-Pro-Pro-Thr-Glu-Val-Gly-Ser-Asn-Thr-Tyr-NH2 (Methylene bridge: Cys2-Cys7)
    ECHEMI Editorial Reference

    Eloralintide (CAS No. 2883634-40-8) is a long-acting amylin analog and peptide-based pharmaceutical ingredient. Its modified peptide structure features a methylene thioacetal bridge and a C20 fatty diacid side chain, contributing to its distinctive molecular and physicochemical properties. As a peptide pharmaceutical raw material, Eloralintide is suitable for API research, analytical studies, and pharmaceutical development.

    Basic Info
    Product Name:

    Eloralintide

    Other Name:

    Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

    CAS No.:

    2883634-40-8

    Molecular Weight:

    0

    EC Number:

    262-076-3

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) agonist (peptide, long-acting)

    Status:

    Investigational — Phase 1/2 (T2DM and obesity)

    Mechanism:

    Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.

    Activity note:

    Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.

    Source:

    MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.

    References
    PubChem:

    PubChem

    Disclaimer:

    Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Pharmaceutical Peptide,Cosmetic peptide,Custom peptides,API polypeptide,Amino acids and derivatives,Peptide - Teriparatide

    Location:

    5th Floor, Building 1, No. 600 Yinhai Street, Xiasha Street

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    7 days

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    51-100

    Year of Establishment:

    2014

    Hangzhou Go Top Peptide Biotech , established in 2014, is a technology-based peptide company and a National High-tech Enterprise located in Hangzhou of China. It is also the governing unit of Peptide Branch of China Biochemical Pharmaceutical Industry Association. 

    The company currently has a peptide research center in Hangzhou, covering an area of 2,000m2 . There are two cooperation plants for peptide commercialization located in Shangyu and Anji of Zhejiang province.  The peptide center has equipped with several complete peptide productions lines, including several large-scale peptide synthesizers and advanced imported HPLC systems with different sizes. We also have GMP standard clean laboratories to meet client’s special needs. The company has passed ISO9001:2015 certification.

    At present, the company has developed more than 40 mature pharmaceutical peptides, with the annual production capacity up to 100 kilograms. With a total of 20,000 custom peptides so far, we can provide the one-stop peptide services from research scale (mg) - pilot scale - commercial production(KGs).


    English web site  https://www.gtpeptide.com

    Products and Services

    1.Custom peptide synthesis, such as Research peptide, Neoantigen peptide, Clinical peptide.

    2.Pharmaceutical peptide development and production.

    3.Peptide CRO and CDMO.

    4. Cosmetic peptide and formulation development.

    5. Special protected amino acids and small molecules.

    6. Commercialized peptide library.

    7. Technical support of new drug development.


    SHELLY HUDirector of sales13735575465sales1@gotopbio.com
       Cindy MeiThe sales manager13588827304sales3@gotopbio.com




  • Inquiry History
    81 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Eloralintide

    1 KG May 28, 2026
    Australia

    ELORALINTIDE

    10 PCS Oct 2, 2026
    United Kingdom

    Eloralitide

    2 G Sep 27, 2026
    United Kingdom

    Eloralintide

    30 MG Sep 22, 2026
    United States

    Eloralintids

    10 MG Sep 18, 2026
    United States

    Eloralintide

    10 MG Sep 13, 2026
    United Kingdom

    Eloralintide

    1 G Sep 1, 2026
    United States

    Eloralintide

    1 MT Aug 31, 2026
    United States

    Eloralintide

    1 G Aug 27, 2026
    Italy

    Eloralintide

    5 PCS Aug 19, 2026
    United States

    eloralintide

    2 PCS Aug 2, 2026
    United States

    eloralintide

    30 MG Jul 28, 2026
    United States

    Elora

    32 G Jul 27, 2026
    United States

    Eloralintide

    1 G Jul 13, 2026
    United States

    Eloralintide

    10 PCS Jul 11, 2026
    Singapore

    Eloralintide

    1 G Jul 1, 2026
    United States

    eloralintide

    50 MT Jun 12, 2026
    United States

    Eloralintide and Retatrutide

    2 MT Jun 8, 2026
    United States

    Eloralintide

    5 PCS May 27, 2026
    South Korea

    eloralintide

    2 G Feb 24, 2026
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.